AVNS Relative Valuation
AVNS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AVNS is overvalued; if below, it's undervalued.
Historical Valuation
Avanos Medical Inc (AVNS) is now in the Undervalued zone, suggesting that its current forward PE ratio of 11.59 is considered Undervalued compared with the five-year average of 18.80. The fair price of Avanos Medical Inc (AVNS) is between 11.93 to 25.12 according to relative valuation methord. Compared to the current price of 11.13 USD , Avanos Medical Inc is Undervalued By 6.69%.
Relative Value
Fair Zone
11.93-25.12
Current Price：11.13
6.69%
Undervalued
11.59
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Avanos Medical Inc. (AVNS) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 9.96. The thresholds are as follows: Strongly Undervalued below -1.88, Undervalued between -1.88 and 4.04, Fairly Valued between 15.88 and 4.04, Overvalued between 15.88 and 21.80, and Strongly Overvalued above 21.80. The current Forward EV/EBITDA of 0.00 falls within the Undervalued range.
0.00
EV/EBIT
Avanos Medical Inc. (AVNS) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 13.09. The thresholds are as follows: Strongly Undervalued below -1.12, Undervalued between -1.12 and 5.99, Fairly Valued between 20.20 and 5.99, Overvalued between 20.20 and 27.30, and Strongly Overvalued above 27.30. The current Forward EV/EBIT of 0.00 falls within the Undervalued range.
0.75
PS
Avanos Medical Inc. (AVNS) has a current PS of 0.75. The 5-year average PS is 1.59. The thresholds are as follows: Strongly Undervalued below 0.38, Undervalued between 0.38 and 0.98, Fairly Valued between 2.19 and 0.98, Overvalued between 2.19 and 2.79, and Strongly Overvalued above 2.79. The current Forward PS of 0.75 falls within the Undervalued range.
0.00
P/OCF
Avanos Medical Inc. (AVNS) has a current P/OCF of 0.00. The 5-year average P/OCF is 13.32. The thresholds are as follows: Strongly Undervalued below -8.59, Undervalued between -8.59 and 2.37, Fairly Valued between 24.28 and 2.37, Overvalued between 24.28 and 35.24, and Strongly Overvalued above 35.24. The current Forward P/OCF of 0.00 falls within the Undervalued range.
0.00
P/FCF
Avanos Medical Inc. (AVNS) has a current P/FCF of 0.00. The 5-year average P/FCF is 25.03. The thresholds are as follows: Strongly Undervalued below -97.84, Undervalued between -97.84 and -36.41, Fairly Valued between 86.47 and -36.41, Overvalued between 86.47 and 147.90, and Strongly Overvalued above 147.90. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Avanos Medical Inc (AVNS) has a current Price-to-Book (P/B) ratio of 0.66. Compared to its 3-year average P/B ratio of 0.79 , the current P/B ratio is approximately -15.92% higher. Relative to its 5-year average P/B ratio of 0.99, the current P/B ratio is about -32.67% higher. Avanos Medical Inc (AVNS) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 7.07%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 5.33% , the current FCF yield is about -100.00% lower.
0.66
P/B
Median3y
0.79
Median5y
0.99
14.27
FCF Yield
Median3y
7.07
Median5y
5.33
Competitors Valuation Multiple
The average P/S ratio for AVNS's competitors is , providing a benchmark for relative valuation. Avanos Medical Inc Corp (AVNS) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 4.34%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of AVNS decreased by 30.09% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.58 to -1.10.
The secondary factor is the Revenue Growth, contributed 4.34%to the performance.
Overall, the performance of AVNS in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Avanos Medical Inc (AVNS) currently overvalued or undervalued?
What is Avanos Medical Inc (AVNS) fair value?
How does AVNS's valuation metrics compare to the industry average?
What is the current P/B ratio for Avanos Medical Inc (AVNS) as of Dec 05 2025?
What is the current FCF Yield for Avanos Medical Inc (AVNS) as of Dec 05 2025?
What is the current Forward P/E ratio for Avanos Medical Inc (AVNS) as of Dec 05 2025?